This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: 33 Medical, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Nick Manesis: Innovator in Discogenic Pain Treatment
Introduction
Nick Manesis is an accomplished inventor based in Escondido, California. He has made significant contributions to the field of medical treatments, particularly focusing on discogenic pain. His innovative approach has led to the development of a unique composition aimed at alleviating this type of pain.
Latest Patents
Nick Manesis holds 1 patent for his invention titled "Compositions for treatment of discogenic pain, and processes for making and using the same." This patent discusses various embodiments of a composition that includes PMMA microparticles, Pluronic® surfactant, PBS, and a radio marker. The PMMA microparticles are designed to have a particle size distribution between 25-125 microns and are nonlinearly cross-linked. The composition is intended to be stored at a cooled temperature and transitions to a gel state upon injection, providing effective treatment for patients suffering from discogenic pain.
Career Highlights
Throughout his career, Nick has demonstrated a commitment to advancing medical technology. His work at 33 Medical, Inc. has positioned him as a key player in the development of innovative solutions for pain management. His dedication to research and development has resulted in significant advancements in the treatment of discogenic pain.
Collaborations
Nick has collaborated with notable professionals in the field, including Jeff Zisselman and Richard Wesley Sierk, III. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Nick Manesis is a pioneering inventor whose work in the treatment of discogenic pain showcases his dedication to improving patient outcomes. His innovative compositions and collaborative efforts continue to make a significant impact in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile